Prevention

What Clinicians Need to Know About Influenza, Pneumococcal Vaccines in Rheumatic Diseases

By

Meghna Rao

Publish Date May 1, 2020

Rheumatologists are recommended to have a working knowledge of vaccines for patients with rheumatic disease, and immunization must be individualized based on a shared decision-making process between the healthcare provider and patient.

Mountaintop Removal Mining Pollution Driving Respiratory Health Risks

By

Tori Rodriguez, MA, LPC, AHC

Publish Date May 30, 2019

Although mountaintop removal mining is less expensive and more efficient than conventional methods, opponents have criticized its adverse effects on both the environment and health.

Collaborative Care Model Improves Mental Health in Respiratory Disease

By

Tori Rodriguez, MA, LPC, AHC

Publish Date April 24, 2019

Providers and patients may not recognize signs of mental health disorders because they often overlap with those of respiratory diseases.

CureVac’s COVID-19 Vaccine Only 47% Effective

A final analysis from the trial of the mRNA vaccine, which included 40,000 volunteers in Latin America and Europe, is expected in two to three weeks.

US to Spend $3.2 Billion to Help Develop Antiviral Pills for COVID-19

The US said Thursday that it will now devote $3.2 billion to the development of antiviral pills that could stop the new coronavirus before it does its worst damage.

Disparities in COVID-19 Vaccination Identified Among Health Employees

Among health care system employees, there are considerable disparities in COVID-19 vaccination rates by race/ethnicity and occupation.

Some Prisons Highly Successful in Vaccinating Inmates

Some prison systems in the United States have been able to vaccinate high numbers of inmates against COVID-19.

WHO Approves Second Chinese COVID-19 Vaccine

China’s Sinovac COVID-19 vaccine has been approved for emergency use authorization in adults 18 years and older.

BNT162b2 Vaccine Safe, Effective for Teens Aged 12 to 15 Years

The BNT162b2 COVID-19 vaccine was reported having a favorable safety and side-effect profile for adolescents aged 12 to 15 years.

Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Indian Variant

Two doses of the Pfizer and AstraZeneca COVID-19 vaccines are effective against the coronavirus variant first identified in India.

WHO: Approved Vaccines “Respond” to All COVID-19 Variants So Far

Vaccines approved for use in the US and Europe show protection against all of the more infectious coronavirus variants known to be circling the globe.